Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Capsule Endoscopy | 5 | 2019 | 35 | 0.940 |
Why?
|
| Cathartics | 1 | 2017 | 9 | 0.530 |
Why?
|
| Gastrointestinal Hemorrhage | 4 | 2019 | 78 | 0.520 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 36 | 0.510 |
Why?
|
| Colitis, Microscopic | 1 | 2015 | 2 | 0.480 |
Why?
|
| Ileostomy | 1 | 2015 | 27 | 0.470 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 172 | 0.420 |
Why?
|
| Endoscopy, Digestive System | 3 | 2025 | 33 | 0.410 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 378 | 0.410 |
Why?
|
| Diet | 1 | 2017 | 526 | 0.400 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2021 | 74 | 0.330 |
Why?
|
| Biliary Tract Diseases | 1 | 2025 | 22 | 0.230 |
Why?
|
| Bile Duct Neoplasms | 1 | 2025 | 54 | 0.230 |
Why?
|
| Cholestasis | 1 | 2025 | 65 | 0.230 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 178 | 0.190 |
Why?
|
| Colonoscopy | 2 | 2018 | 100 | 0.170 |
Why?
|
| Suture Techniques | 1 | 2021 | 101 | 0.170 |
Why?
|
| Hematemesis | 1 | 2018 | 6 | 0.150 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 47 | 0.140 |
Why?
|
| Viral Core Proteins | 2 | 2007 | 31 | 0.120 |
Why?
|
| Remission Induction | 1 | 2015 | 148 | 0.120 |
Why?
|
| Risk Reduction Behavior | 1 | 2015 | 121 | 0.110 |
Why?
|
| Patient Selection | 1 | 2017 | 490 | 0.110 |
Why?
|
| Recurrence | 1 | 2015 | 641 | 0.100 |
Why?
|
| Dendritic Cells | 3 | 2012 | 525 | 0.100 |
Why?
|
| Interleukins | 1 | 2012 | 80 | 0.100 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 480 | 0.090 |
Why?
|
| Middle Aged | 9 | 2025 | 17609 | 0.090 |
Why?
|
| Hepatitis C, Chronic | 2 | 2012 | 88 | 0.090 |
Why?
|
| Humans | 12 | 2025 | 63465 | 0.080 |
Why?
|
| Aged | 6 | 2025 | 14443 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2021 | 5686 | 0.080 |
Why?
|
| Standard of Care | 2 | 2019 | 27 | 0.080 |
Why?
|
| Risk Factors | 2 | 2018 | 5356 | 0.080 |
Why?
|
| Male | 10 | 2025 | 29907 | 0.070 |
Why?
|
| Female | 10 | 2025 | 32890 | 0.070 |
Why?
|
| Macrophage Activation | 1 | 2007 | 119 | 0.070 |
Why?
|
| Endotoxins | 1 | 2007 | 81 | 0.060 |
Why?
|
| Hepacivirus | 2 | 2007 | 141 | 0.060 |
Why?
|
| Toll-Like Receptors | 1 | 2007 | 431 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2007 | 567 | 0.060 |
Why?
|
| Constriction, Pathologic | 1 | 2025 | 129 | 0.060 |
Why?
|
| Time Factors | 3 | 2018 | 3771 | 0.060 |
Why?
|
| Biopsy | 1 | 2025 | 444 | 0.050 |
Why?
|
| Growth Inhibitors | 1 | 2003 | 26 | 0.050 |
Why?
|
| Isoantigens | 1 | 2003 | 71 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 5462 | 0.050 |
Why?
|
| Length of Stay | 2 | 2019 | 813 | 0.050 |
Why?
|
| Interleukin-2 | 1 | 2003 | 167 | 0.050 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2003 | 93 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2003 | 160 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2003 | 319 | 0.050 |
Why?
|
| Monocytes | 3 | 2012 | 353 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2021 | 6660 | 0.050 |
Why?
|
| Sutures | 1 | 2021 | 42 | 0.050 |
Why?
|
| Hepatitis C | 1 | 2003 | 151 | 0.040 |
Why?
|
| Ethanol | 1 | 2003 | 321 | 0.040 |
Why?
|
| Equivalence Trials as Topic | 1 | 2019 | 14 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 102 | 0.040 |
Why?
|
| Cytokines | 1 | 2003 | 935 | 0.040 |
Why?
|
| Melena | 1 | 2018 | 5 | 0.040 |
Why?
|
| Unnecessary Procedures | 1 | 2018 | 49 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2018 | 99 | 0.030 |
Why?
|
| Stents | 1 | 2021 | 503 | 0.030 |
Why?
|
| Cell Differentiation | 3 | 2012 | 1353 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 422 | 0.030 |
Why?
|
| Anemia | 1 | 2018 | 127 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 182 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 730 | 0.030 |
Why?
|
| Adult | 5 | 2018 | 16829 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 937 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1277 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2012 | 34 | 0.020 |
Why?
|
| Vascular Malformations | 1 | 2013 | 22 | 0.020 |
Why?
|
| Receptors, Interferon | 1 | 2012 | 21 | 0.020 |
Why?
|
| Myeloid Cells | 2 | 2003 | 94 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 3294 | 0.020 |
Why?
|
| Interferons | 1 | 2012 | 73 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2012 | 211 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2013 | 311 | 0.020 |
Why?
|
| Inflammation | 2 | 2007 | 1148 | 0.020 |
Why?
|
| Liver | 1 | 2012 | 855 | 0.020 |
Why?
|
| Kupffer Cells | 1 | 2007 | 43 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2007 | 223 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2012 | 796 | 0.020 |
Why?
|
| Ligands | 1 | 2007 | 416 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2007 | 344 | 0.020 |
Why?
|
| Hospitalization | 1 | 2013 | 1361 | 0.010 |
Why?
|
| United States | 1 | 2018 | 7842 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2007 | 469 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 615 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 624 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 1122 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 215 | 0.010 |
Why?
|
| Viral Envelope Proteins | 1 | 2003 | 103 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 450 | 0.010 |
Why?
|
| Macrophages | 1 | 2007 | 1039 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2003 | 314 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 1008 | 0.010 |
Why?
|
| Apoptosis | 1 | 2003 | 1079 | 0.010 |
Why?
|